Lisa Forman, MD
Professor, Medicine-Gastroenterology

Research Interests

Publications

• Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology. 2023 Aug 1;78(2):397-415. PubMed PMID: 37386786
• Bowlus CL, Eksteen B, Cheung AC, Thorburn D, Moylan CA, Pockros PJ, Forman LM, Dorenbaum A, Hirschfield GM, Kennedy C, Jaecklin T, McKibben A, Chien E, Baek M, Vig P, Levy C. Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatol Commun. 2023 Jun 1;7(6). PubMed PMID: 37184523
• Forman LM, Sapisochin G, Assis DN, Arrivé L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian JH. Reply: Living donor liver transplantation for people with PSC. Hepatology. 2023 May 1;77(5):E97-E98. PubMed PMID: 36732294
• Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Reply: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology. 2023 Jun 1;77(6):E176-E177. PubMed PMID: 36695291
• Martinez-CAmacho A< Fortune BE, Forman L. Hepatic Encephalopathy. In Vincent LJ, Moore F, Belloma R, MAriniJ (eds): Textbook of Critical Care, Elssevier Press 2022
• Bowlus CL, Arrive L, Bergquits A, Deneau M, Forman L, et al. AASLD Practice Guidance on PSCA and CCA. Hepatology2022 Sep 9. Doi: 10.1002/hep.32771
• Swei EC, Bar AK, Rice JD, Doe CF, Forman LM, Statin-induced rhabdomyolysis associated with TIPS. ACG Case Rep J 2022:9:e00774
• Mayo MJ, Carey E. et al. Impact of Pruritus on QOL and Current Treatment Patterns in Patients with PBC.Dig Dis Sc 2022;
• Krowdley KV, Forman LM, Eksteen B et al. A randomized, dose finding, proof of concept Study of Berberine Ursodeoxycholate in PAtients with PSC. AM J GAstro;2022:17:1805015
• Kowdley KV, Forman L, Eksteen B, Gunn N, Sundaram V, Landis C, Harrison SA, Levy C, Liberman A, Di Bisceglie AM, Hirschfield GM. A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis. Am J Gastroenterol. 2022 Nov 1;117(11):1805-1815. PubMed PMID: 36327436
• Yan K, Forman L. Cannabinoid Use Among Liver Transplant Recipients. Liver Transpl. 2021 Nov;27(11):1623-1632. PubMed PMID: 34018308
• Francis P, Forman L. HATs Off to Clot Blockers: A Potential New Role for Statins After Transplantation. Liver Transpl. 2021 Oct;27(10):1375-1377. PubMed PMID: 34118130
• Cristin DJ, Forman LM, Jackson WE.Beyond survival: Targeting health-related quality of life outcomes after liver transplant. Clin Liver Dis 2021;17:359-64.
• Francis P, Forman L. Statins show promise against progression of liver disease. Liver Transpl 2021;18:280-7
• Frances P, Forman L. Use of statins in patients with and without liver disease. Clin Liv Dis 2020;15(1):40-45
• Bowlus CL, Pockros PJ et al. Long term obeticholic acid therapy improves histology in patients with primary biliary cholangitis. Clin Gastroenterol Hepatol 2020;28(5):1170-1178
• Francis P, Forman L. Use of Statins in Patients With and Without Liver Disease. Clin Liver Dis (Hoboken). 2020 Jan;15(1):40-45. PubMed PMID: 32104577
• Bowlus CL, Pockros PJ, Kremer AE, Parés A, Forman LM, Drenth JPH, Ryder SD, Terracciano L, Jin Y, Liberman A, Pencek R, Iloeje U, MacConell L, Bedossa P. Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2020 May;18(5):1170-1178.e6. PubMed PMID: 31606455
• Leehey MA, Liu Y, Hart F, Epstein C, Cook M, Sillau S, Klawitter J, Newman H, Sempio C, Forman L, Seeberger L, Klepitskaya O, Baud Z, Bainbridge J. Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study. Cannabis Cannabinoid Res. 2020;5(4):326-336. PubMed PMID: 33381646

Professional Memberships

• American Gastroenterological Association (AGA), Member
• American Association for the Study of Liver Diseases (AASLD), Member
• American Medical Association (AMA), Member
• American Society for Transplantation, Member
• American College of Physicians (ACP), Member